Giulio Piedimonte MD, Lorenzo Azzalini MD, PhD, MSc, Luigi Ferrarotto MD, Riccardo Mangione MD, Enrico Cerrato MD, PhD, Alfonso Franzè MD, Francesco Tomassini MD, Cristina Rolfo MD, Marco Pavani MD, Greca Zanda MD, Corrado Tamburino MD, PhD, Ferdinando Varbella MD, Alessio La Manna MD
doi : 10.1002/ccd.30928
Bahadir Simsek MD, Athanasios Rempakos MD, Spyridon Kostantinis MD, Michaella Alexandrou MD, Judit Karacsonyi MD, PhD, Bavana V. Rangan BDS, MPH, Olga C. Mastrodemos BA, Deniz Mutlu MD, Nidal Abi Rafeh MD, Khaldoon Alaswad MD, Alexandre Avran MD, Lorenzo Azzalini MD, PhD, MSc, Ahmed ElGuindy MD, Mohaned Egred MD, Omer Goktekin MD, Sevket Gorgulu MD, Wissam Jaber MD, Kathleen E. Kearney MD, Ajay J. Kirtane MD, SM, William L. Lombardi MD, Kambis Mashayekhi MD, Margaret McEntegart MD, William Nicholson MD, Stephane Rinfret MD, SM, Salman S. Allana MD, Yader Sandoval MD, M. Nicholas Burke MD, Emmanouil S. Brilakis MD, PhD
doi : 10.1002/ccd.30914
Christopher M. Fernandez MD, MHS, Adhir R. Shroff MD, Mladen I. Vidovich MD
doi : 10.1002/ccd.30930
Percutaneous coronary intervention (PCI) without surgical backup is becoming increasingly common in the United States. Additionally, a recent SCAI expert consensus document has liberalized recommendations for performing PCI without cardiac surgery on site (SOS).
Awad I. Javaid MD, Joel E. Michalek PhD, Aleksandra B. Gruslova PhD, Serene A. Hoskins BS, Chowdhury H. Ahsan MD, Marc D. Feldman MD
doi : 10.1002/ccd.30913
Previous studies have compared Impella use to intra-aortic balloon pump (IABP) use in patients with acute myocardial infarction and cardiogenic shock (AMI-CS) undergoing percutaneous coronary intervention (PCI). Our objective was to compare clinical outcomes in patients with AMI-CS undergoing PCI who received Impella (percutaneous left ventricular assist device) without vasopressors, IABP without vasopressors, and vasopressors without mechanical circulatory support (MCS).
Akito Kawamura MD, Yasuyuki Egami MD, Naotaka Okamoto MD, Shodai Kawanami MD, Koji Yasumoto MD, Masaki Tsuda MD, Yasuharu Matsunaga-Lee MD, Masamichi Yano MD, PhD, Masami Nishino MD, PhD, FESC, Keita Okayama MD, PhD
doi : 10.1002/ccd.30925
Debulking devices are necessary to treat severe calcified lesions. OAS has a unique characteristic that the burr moves forward and backward. There are few studies reporting the differences of ablation style between only-antegrade and only-retrograde OAS.
Ankush Gupta MD, DM, Abhinav Shrivastava MD, DM, Sanya Chhikara MBBS, Mamas A. Mamas MBChB, DPhil, Rajesh Vijayvergiya MD, DM, Ajay Swamy MD, DM, Nalin K. Mahesh MD, DNB, Navreet Singh MD, DM, Nitin Bajaj MD, DM, Balwinder Singh MD, DNB, Daulat Singh Meena MD, DM, Chandraket Singh MD
doi : 10.1002/ccd.30915
Among the two stent strategies, contemporary evidence favors double kissing crush technique (DKC) for complex unprotected distal left main bifurcation (UdLMB) lesions. However one of the major challenges to these lesions is side branch (SB) restenosis.
Ziad Arow MD, Maayan Konigstein MD, Hana Vaknin-Assa MD, Guy Witberg MD, Michael Jonas MD, Arthur Kerner MD, Carlos Cafri MD, Ronen Rubinshtein MD, Amit Segev MD, Ariel Roguin MD, Melek Ozgu Issever MD, Mustafa Gabarin MD, David Pereg MD, Abid Assali MD, Edward Koifman MD
doi : 10.1002/ccd.30924
The ridaforolimus-eluting stent (RES) system uses a novel cobalt alloy-based coronary stent with a durable elastomeric polymer eluting ridaforolimus.
Claudiu Ungureanu MD, Mihai Cocoi MD, Giuseppe Colletti MD, Alexandre Avran MD
doi : 10.1002/ccd.30904
Complex coronary total occlusion (CTO) lesions percutaneous treatment, especially in contexts where traditional antegrade strategies have failed and retrograde approaches are unsuitable, due to lack of interventional collaterals or high risk of complications, presents a considerable challenge for interventional cardiologists.
Roberto Garbo MD, Mario Iannaccone MD, Francesco Bruno MD, Manfredi Arioti MD
doi : 10.1002/ccd.30920
The use of the subintimal space has allowed a massive advancement in the field of chronic total occlusion percutaneous coronary intervention (PCI). The STAR technique is the first of subintimal techniques.
Nikoloz Shekiladze MD, Pratik B. Sandesara MD, Zaheed Tai DO, Nodar Maisuradze MD, Wissam Jaber MD, William Nicholson MD
doi : 10.1002/ccd.30923
This article highlights four unique cases where rotational atherectomy (RA Rotapro, Boston Scientific) was used to cut and retrieve an entrapped coronary guidewire with parts extending into the aorta We discuss the technique and step by step approach to the retrieval procedure.
Takuya Haraguchi MD, Shoichi Kuramitsu MD, PhD, Masanaga Tsujimoto MD, Yoshifumi Kashima MD, Katsuhiko Sato MD, Tsutomu Fujita MD
doi : 10.1002/ccd.30911
Whether drug-coated balloon (DCB) angioplasty would be effective in spiral dissection (SD) lesions with no flow impairment has been thoroughly investigated.
Valery S. Effoe MD, MS, Mark W. Mewissen MD, Tanvir K. Bajwa MD, Jayant Khitha MD, Louie Kostopoulos MD, Khawaja A. Ammar MD, Tonga K. Nfor MD, MSPH
doi : 10.1002/ccd.30912
Atherectomy use in treatment of femoropopliteal disease has significantly increased despite scant evidence of benefit to long-term clinical outcomes.
Zachary L. Steinberg MD, Samuel G. Rayner MD, Peter J. Leary MD, PhD
doi : 10.1002/ccd.30919
Zhong-bao Ruan MD, FACC, Wei Li MM, Kai Jin MM, Xiang-wei Ding MD, Ge-cai Chen MM, Jun-guo Zhu MM, Yi Ren, Li Zhu MD
doi : 10.1002/ccd.30838
Left atrial appendage occlusion (LAAO) has been considered an alternative treatment to prevent embolic stroke in patients with nonvalvular atrial fibrillation (NVAF). However, it carries a risk of general anesthesia or esophageal injury if guided by transesophageal echocardiography (TEE).
Mohammad Atif Rana MD, Sunghan Yoon MD, Luis Augusto Palma Dallan MD, PhD, Nour Tashtish MD, Guilherme F. Attizzani MD, Imran Rashid MD, PhD, Sanjay Rajagopalan MD, Mauricio Arruda MD, Steven J. Filby MD
doi : 10.1002/ccd.30843
While studies have shown the advantages of computed tomography angiography (CTA) over transesophageal echocardiography (TEE) in left atrial appendage closure (LAAC) preprocedural planning for WATCHMANâ„¢ legacy and FLX devices, there has been no reported long-term data for this approach.
Tobias Geisler MD, Juergen Schreieck MD, Miriam Euper MD, Monika Zdanyte MD, Andreas Goldschmied MD, Meinrad Gawaz MD, Peter Bramlage MD, Jean M. Haurand MD, Malte Kelm MD, Patrick Horn MD
doi : 10.1002/ccd.30866
The development of the PASCAL transcatheter valve repair system for treating mitral regurgitation (MR) greatly extends therapeutic options.
Joseph Heaton MD, Steven Imburgio MD, Sowmya Dandu MD, Anmol Johal MD, Ndausung Udongwo MD, Anton Mararenko DO, Arif Asif MD, Jesus Almendral MD, Brett Sealove MD, Jeffrey Selan MD, Daniel Kiss MD, Matthew Saybolt MD
doi : 10.1002/ccd.30857
Transcatheter edge-to-edge repair (TEER) devices are used for primary mitral regurgitation (MR) and secondary MR. Despite the growing use of TEER devices, there have not been many studies on operator experience or procedure volumes by state.
Ye Yang MD, Jinmiao Chen MD, PhD, Lili Dong MD, PhD, Yuntao Lu MD, Minzhi Lv MD, Kefang Guo MD, Ghufran Bagaber MBBS, Jian Yang MD, PhD, Chunsheng Wang MD, Lai Wei MD, PhD
doi : 10.1002/ccd.30926
Transcatheter mitral valve replacement (TMVR) has become an alternative for high-risk patients with severe mitral regurgitation (MR). The aim of this study was to evaluate the safety and feasibility of the Mi-thos TMVR system (NewMed Medical) for high-risk patients with severe MR.
Israel M. Barbash MD, Yishay Wasserstrum MD, Magdalena Erlebach MD, Victor Guetta MD, Johannes Ziegelmüller MD, Amit Segev MD, Paul Fefer MD, Elad Maor MD, Rüdiger Lange MD, Hendrik Ruge MD
doi : 10.1002/ccd.30921
New vascular closure devices (VCD) are being introduced for achieving hemostasis after transcatheter aortic valve implantation (TAVI). However, no safety or efficacy data have been published compared to other contemporary VCD.
Vitaliy Androshchuk MBBCh, Omar Chehab MB, BS, Bernard Prendergast BM, BS, MD, Ronak Rajani BM, MD, Tiffany Patterson MB, BS, PhD, Simon Redwood MB, BS, MD
doi : 10.1002/ccd.30918
Vascular complications after percutaneous transfemoral transcatheter aortic valve implantation (TAVI) are associated with adverse clinical outcomes and remain a significant challenge.
Julius Fischer MD, Julius Steffen MD, Tobias Arlart, Magda Haum MD, Sarah Gschwendtner MD, Philipp M. Doldi MD, MSc, Konstantinos Rizas MD, Hans Theiss MD, Daniel Braun MD, Martin Orban MD, Sven Peterß, Jörg Hausleiter MD, Steffen Massberg MD, Simon Deseive MD … See fewer authors
doi : 10.1002/ccd.30927
Patients undergoing transcatheter aortic valve implantation (TAVI) frequently have coronary artery disease requiring percutaneous coronary intervention (PCI). Usually, PCI and TAVI are performed in two separate procedures and current studies are investigating potential benefits regarding the order.
Yvonne Schneeberger MD, MHBA 1 | Harun Sarwari MD 1 | Benedikt K?ll MD 2 | Till J. Demal MD 1 | Oliver D. Bhadra MD 1 | Ina von der Heide MD 2 | Laura Hannen MD 2 | David Grundmann MD 2 | Lisa Voigtl?nder MD 2 | Lara Waldschmidt MD 2 | Johannes Schirmer MD 1 | Simon Pecha MD 1 | Niklas Schofer MD 2 | Nils S?rensen MD 2 | Stefan Blankenberg MD 2 | Hermann Reichenspurner MD, PhD1 | Lenard Conradi MD 1 | Moritz Seiffert MD 2 | Andreas Schaefer MD, MHBA
doi : 10.1002/ccd.30922
Transcatheter aortic valve implantation (TAVI) using balloon-expandable (BE) transcatheter heart valves (THV) in aortic annuli above 29 mm includes particular procedural steps, mainly involving overfilling of the deployment balloon. Data on overfilling strategies in clinical daily practice is scarce. We herein aimed for a retrospective description of utilized overfilling strategies in those patients.
Talal F. Aljabbary MD, Ikki Komatsu MD, PhD, Tomoki Ochiai MD, Stephen E. Fremes MD, Noman Ali MD, Lucas Burke MD, Mark D. Peterson MD, PhD, Neil P. Fam MD, MSc, Harindra C. Wijeysundera MD, PhD, Sam Radhakrishnan MD
doi : 10.1002/ccd.30910
Conduction disturbances and the need for permanent pacemaker (PPM) implantation remains a common complication for transcatheter aortic valve replacement (TAVR), particularly when self-expanding (SE) valves are used.
Jorge Sanz Sánchez MD, Damiano Regazzoli MD, Marco Barbanti MD, Claudia Fiorina MD, Marianna Adamo MD, Marco Angelillis MD, Marco De Carlo MD, Barbara Bellini MD, Matteo Montorfano MD, Antonio Mangieri MD, Giuseppe Bruschi MD, Bruno Merlanti MD, Mauro Luca Agnifili MD, Luca Testa MD, Erica Ferrara MD, Carmine Musto MD, Antonio Colombo MD, Corrado Tamburino MD, Bernhard Reimers MD
doi : 10.1002/ccd.30907
Balloon post-dilation (BPD) is a widely adopted strategy to optimize acute results of TAVI, with a positive impact on both paravalvular leak and mean gradients. On the other hand, the inflation of the balloon inside prosthetic leaflets may damage them increasing the risk of structural valve deterioration (SVD). Furthermore, the impact of BPD on long-term clinical outcomes and valve hemodynamics is yet unknown.
Gökhan Demirci MD, Serkan Aslan MD, Ahmet Güner MD, Ali R. Demir MD, Yunus E. Erata MD, İrem Türkmen MD, Ahmet A. Yalçın MD, Ali K. Kalkan MD, Fatih Uzun MD, Ömer Çelik MD, Mehmet Ertürk MD
doi : 10.1002/ccd.30929
One of the hallmarks of frailty in patients with severe aortic stenosis (AS) is malnutrition, for which one of the most up-to-date scoring systems is the Naples prognostic score (NPS). This study sought to investigate the predictive role of the NPS in determining mortality in patients undergoing transcatheter aortic valve replacement (TAVR) under long-term follow-up.
Sung-Han Yoon MD, Akram Y. Elgendy MD, Luis Augusto Palma Dallan MD, Steven J. Filby MD
doi : 10.1002/ccd.30864
Peri-device leak after left atrial appendage closure (LAAC) is often treated with endovascular coils, plugs, or second occluders. This is the first study reporting the Amulet device used for peri-device leak. An 80-year-old male with paroxysmal atrial fibrillation and recurrent falls with head trauma who underwent LAAC with a 24 mm Watchman 2.5 device 3 years ago at another institution was referred to our clinic for management of the peri-device leak.
Fuyu Cheng MD, Zhiqing Qiao MD, PhD, Liang Zhao MD, Jun Pu MD, PhD
doi : 10.1002/ccd.30826
Absence of periprocedural visualization of three-dimensional (3D) left heart anatomy and its surrounding structures in fluoroscopy may reduce the rate of successful transcatheter mitral valve repair.
Ningyan Wong MBBS, Dale Fowler MD, RDCS, D. Scott Lim MD
doi : 10.1002/ccd.30897
Transcatheter mitral valve-in-valve (ViV) has emerged as a safe and effective therapeutic option for patients with a degenerated mitral bioprosthesis. As procedural techniques mature and operator experience improve, there is a push to adopt a “minimalist� approach of using conscious sedation instead of general anesthesia for faster recovery.
A 75-year-old female was found to have mechanical mitral valve thrombosis complicated by severe mitral stenosis, pulmonary edema, and right heart failure. She was at prohibitive risk for surgical intervention. She did not tolerate thrombolysis due to bleeding. We performed percutaneous intervention with cerebral protection with subsequent restoration of mechanical mitral valve function, resolution of the mitral valve stenosis, and no neurologic complications.
doi : 10.1002/ccd.30900
Shilpa Sharma MD, Mamoo Nakamura MD
Ping Jin MD, PhD, Yiwei Wang MD, PhD, Yang Liu MD, PhD, Jian Yang MD, PhD, FAHA
doi : 10.1002/ccd.30874
A mitral paravalvular leak (PVL) is a significant complication of surgical valve replacement that has a profound impact on the health and survival of patients. Transcatheter closure of PVL has emerged as a promising treatment option.
Do you want to add Medilib to your home screen?